Last reviewed · How we verify
NCT03753152
Neuramis® Deep Lidocaine Compared to YVOIRE® Volume Plus for Correction of Nasolabial Folds
NA trial testing experimental in Nasolabial Folds in 370 participants. Completed in 16 October 2019.
2 April 2019
Quick facts
| Lead sponsor | Medy-Tox |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 370 |
| Start date | 2 April 2018 |
| Primary completion | 2 April 2019 |
| Estimated completion | 16 October 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- experimental — full drug profile →
- comparator
Conditions studied
- Nasolabial Folds — all drugs for Nasolabial Folds →
Sponsor
Medy-Tox — full company profile →
Who can join
Adults 18 to 75, any sex, with Nasolabial Folds. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical investigation is a randomized, evaluator-blind, active controlled, noninferiority study to evaluate the effectiveness and safety of Neuramis® Deep Lidocaine when compared with YVOIRE® Volume Plus.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03753152
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of experimental
Trials testing the same drug.
- NCT07244081 — Kinesiotherapy on Upper Limb Function and Activities of Daily Living in Children With Hemiplegic Cerebral Palsy · NA · recruiting
- NCT07521098 — Effects of PACE Technique in Patients With Aphasia · NA · completed
- NCT06531213 — Visual Perception Intervention Programmes Impact on Down Syndrome Affiliate Children's Fine Motor and Visual Perception. · NA · completed
- NCT06301841 — An Antibiotic Protocol Guided by a Multimodal Approach in AECOPD With Pneumonia in Intensive Care · NA · recruiting
- NCT06350188 — Efficacy of Kinesiotape on Treatment of Nonspecific Cardiac Chest Pain · NA · active not recruiting
Other Medy-Tox trials
Trials by the same sponsor.
- NCT05195112 — Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat · Phase 3 · completed
- NCT04157686 — MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL) · Phase 3 · completed
- NCT04281745 — Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX® · Phase 4 · unknown
- NCT04144049 — A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat · Phase 2 · completed
- NCT04143854 — Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03753152 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medy-Tox
- Last refreshed: 28 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03753152.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing